These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31645265)

  • 1. Blood doping: Then and now. A narrative review of the history, science and efficacy of blood doping in elite sport.
    Atkinson TS; Kahn MJ
    Blood Rev; 2020 Jan; 39():100632. PubMed ID: 31645265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
    Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood transfusion in sports.
    Giraud S; Sottas PE; Robinson N; Saugy M
    Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of erythropoietin abuse on exercise performance.
    Sgrò P; Sansone M; Sansone A; Romanelli F; Di Luigi L
    Phys Sportsmed; 2018 Feb; 46(1):105-115. PubMed ID: 29113535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic enhancement in sport: just another form of doping?
    Mehlman MJ
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):240-6. PubMed ID: 22830451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration.
    Wang G; Durussel J; Shurlock J; Mooses M; Fuku N; Bruinvels G; Pedlar C; Burden R; Murray A; Yee B; Keenan A; McClure JD; Sottas PE; Pitsiladis YP
    BMC Genomics; 2017 Nov; 18(Suppl 8):817. PubMed ID: 29143667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry, physiology, and complications of blood doping: facts and speculation.
    Lippi G; Franchini M; Salvagno GL; Guidi GC
    Crit Rev Clin Lab Sci; 2006; 43(4):349-91. PubMed ID: 16769597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of EPO gene doping in blood.
    Neuberger EW; Jurkiewicz M; Moser DA; Simon P
    Drug Test Anal; 2012 Nov; 4(11):859-69. PubMed ID: 22508654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.
    Nikolopoulos DD; Spiliopoulou C; Theocharis SE
    Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
    Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
    Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
    Elliott S
    Br J Pharmacol; 2008 Jun; 154(3):529-41. PubMed ID: 18362898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.